Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $5.7 million.

  • Medical Group Holdings' Tax Provisions fell 4477.44% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.5 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of $41.2 million for FY2024, which is 1760.28% up from last year.
  • As of Q3 2025, Medical Group Holdings' Tax Provisions stood at $5.7 million, which was down 4477.44% from $11.1 million recorded in Q2 2025.
  • In the past 5 years, Medical Group Holdings' Tax Provisions registered a high of $13.0 million during Q3 2023, and its lowest value of $166728.0 during Q2 2023.
  • Over the past 3 years, Medical Group Holdings' median Tax Provisions value was $10.0 million (recorded in 2025), while the average stood at $8.2 million.
  • As far as peak fluctuations go, Medical Group Holdings' Tax Provisions soared by 679221.73% in 2024, and later plummeted by 4477.44% in 2025.
  • Quarter analysis of 3 years shows Medical Group Holdings' Tax Provisions stood at $8.0 million in 2023, then skyrocketed by 47.99% to $11.8 million in 2024, then plummeted by 51.81% to $5.7 million in 2025.
  • Its Tax Provisions stands at $5.7 million for Q3 2025, versus $11.1 million for Q2 2025 and $10.0 million for Q1 2025.